Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial - Wikidata - awgldk - TriplyDB

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

http://www.wikidata.org/entity/Q28210012

about

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Acoustic cardiography to improve detection of coronary artery disease with stress testing Chronic coronary artery disease: diagnosis and management Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Chronic total occlusion: To treat or not to treat.Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist.How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve.Whole body cardiovascular magnetic resonance imaging to stratify symptomatic and asymptomatic atherosclerotic burden in patients with isolated cardiovascular disease.Fractional flow reserve in 2017: current data and everyday practice.Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study Early vs Late Coronary Angiography and Intervention Following Thrombolytic Therapy; a Cohort Study.Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.Short-Term Left Ventricular Remodeling After Revascularization in Subacute Total and Subtotal Occlusion With the Infarct-Related Left Anterior Descending Artery.Therapeutic strategies in patients with chronic stable coronary artery disease.Revascularization treatment of stable coronary artery disease.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi Multivessel versus culprit-only revascularization: one time versus staged procedures for the ACS population.New insights from major prospective cohort studies with cardiac nuclear imaging.Coronary computed tomography angiography for the assessment of chest pain: current status and future directions.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.[Diagnostics and therapy of chronic stable coronary artery disease : new guidelines of the European Society of Cardiology].Predictors of Medical Management in Patients Undergoing Elective Cardiac Catheterization for Chronic Ischemic Heart Disease.Revascularization for silent ischemia?: another piece of the puzzle.Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve.Diagnostic accuracy of combined coronary angiography and adenosine stress myocardial perfusion imaging using 320-detector computed tomography: pilot study.Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve.Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease.Budget impact of applying appropriateness criteria for myocardial perfusion scintigraphy: The perspective of a developing country.Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.

P2860

Q24642679-F0F9B61F-6D29-48B4-A834-8F80CCF0F4B3 Q30478129-A8A2A3FD-6147-4F21-9E91-3BBBFED59102 Q30492121-4C53E00E-49EB-4A4C-9E7F-3797D0C0C287 Q33675490-67E980E5-BB57-4661-8EAC-94C8B4791887 Q33712205-73441698-EF62-4466-88F4-DD2923534A6F Q33791885-AD12DD75-F04E-4F03-BA39-E6723DA23E3C Q33948505-59E6F0A7-C107-4B20-8211-56BB7A72F140 Q34297136-D8DFB402-9231-4E7D-A357-74F61AA08422 Q34571245-02935112-1331-45EB-BDFC-AF1C854B889C Q34778284-564CD719-14A2-4DE9-82E6-3654F76E649C Q34978684-7A904A75-AF1D-4B43-A255-478A12712695 Q35938672-20B61AAD-DBE9-457E-8C60-3E504E88D335 Q36364120-FFA8A86B-1060-4AC5-81F6-528B763E3007 Q37291498-558C9635-BBCC-4CD5-A3DB-E3B79582A23C Q37666476-22CB9EAC-472E-4F21-94C7-3D2E51CC9CFB Q37682501-CA1E452C-9137-4942-8808-CCADAA36BA48 Q37711476-2B3A52F5-06D3-45F6-AC43-8B8631E0744B Q37759029-559BEADE-2314-461E-9398-BB6E8A7BDA52 Q37827869-0FBC8CD0-569E-458C-8AD0-98DF0638BE8E Q37953885-561A4C66-55EC-4ADB-A982-CE72C6F1A5BD Q38005014-BF39953A-F5DD-4913-8294-B31ED6F051E8 Q38197125-B6D80321-6C28-4BB6-9FE1-FFD420F6A726 Q38541750-F5BDB9FA-EA26-4D1C-BADA-02DA2E91DCAD Q38652030-4666E863-6A4E-4072-AB9D-0AC44FA3A3F7 Q39198816-A0B724B5-C65D-4D5F-91DF-4BEA4FD6237D Q40928026-4DD71D89-9FFA-44B4-837A-DED6E2A95E93 Q43089674-82B7EB11-95A6-4A6B-ADD5-1B0415F898A7 Q44091079-DCF4C98A-0A9E-4454-893F-14883A84AEE4 Q45228893-0FBE5D33-5EFC-4F88-AC1D-441C6EAA6DDD Q47580327-B109E814-45F5-411A-A585-2E42D787D385 Q51514967-2B7EC9BC-E7C3-422A-8C28-D95C80371B97 Q52982721-21ED485A-39EA-4D65-A24A-ABEB560FFBD1 Q53363030-D6E63421-401A-42BC-909A-F6185B376138

P2860

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

http://www.wikidata.org/entity/Q28210012

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Effects of percutaneous corona ...... II randomized controlled trial

@ast

Effects of percutaneous corona ...... II randomized controlled trial

@en

Effects of percutaneous corona ...... II randomized controlled trial

@nl

type

label

Effects of percutaneous corona ...... II randomized controlled trial

@ast

Effects of percutaneous corona ...... II randomized controlled trial

@en

Effects of percutaneous corona ...... II randomized controlled trial

@nl

prefLabel

Effects of percutaneous corona ...... II randomized controlled trial

@ast

Effects of percutaneous corona ...... II randomized controlled trial

@en

Effects of percutaneous corona ...... II randomized controlled trial

@nl

P1433

Q28210012-4C52D859-4527-4B30-BD4F-56EE12958C6F

P1476

Q28210012-DB56601B-7707-4ECB-A72E-23698F9332C1

P2093

Q28210012-22D9CDBB-C9F3-44DE-BAEC-B731CC393B65

Q28210012-836EF448-782D-494A-87C9-ED81360F1D52

Q28210012-91237F39-2DF9-4805-8A8C-75781F31DE2E

Q28210012-941CEFA7-D1C6-49F7-97C1-273D6453D2F1

Q28210012-A0934A25-3624-4001-A753-6851EC255D11

Q28210012-AB4065C3-6110-43B5-A6B8-A1781015EAB6

Q28210012-B402CA04-0CA6-488D-B614-66538567A083

Q28210012-EDC2A5D8-C38B-4ABA-9741-7AFAE0225EDF

Q28210012-F56135F0-CC57-4F23-95D8-90667BAD8FFC

P304

Q28210012-43E60EB0-AA80-4C57-A78B-831DB9D50771

P31

Q28210012-7B840ED6-36CB-4FFB-BA53-161440789A65

P356

Q28210012-2653E729-8CF9-4F99-BEA9-BA72844964BC

P407

Q28210012-3299CC6A-AE8C-475B-B24E-72EE588DFED0

P433

Q28210012-49B995A2-B639-459D-85CE-3ADEABBB7C3B

P478

Q28210012-EF6F16A1-165B-4CA2-9E5C-BAEA3724A9A6

P577

Q28210012-C9C155A5-BBCF-4F81-A14D-7BC9C5E580B5

P5875

Q28210012-614D5D96-A932-4B61-A57B-706E9A96A504

P698

Q28210012-9A553DE1-BD5D-4BCD-93A9-14ED7593EB7E

P921

Q28210012-476F728F-B619-4063-85B0-01129934E8B1

P356

JAMA.297.18.1985

P1433

Journal of the American Medical Association

P1476

Effects of percutaneous corona ...... II randomized controlled trial

@en

P2093

Andreas W Schoenenberger

http://www.w3.org/2001/XMLSchema#string

Dieter Burckhardt

http://www.w3.org/2001/XMLSchema#string

Matthias Pfisterer

http://www.w3.org/2001/XMLSchema#string

Michel Zuber

http://www.w3.org/2001/XMLSchema#string

Paul Dubach

http://www.w3.org/2001/XMLSchema#string

Paul Erne

http://www.w3.org/2001/XMLSchema#string

Peter T Buser

http://www.w3.org/2001/XMLSchema#string

Therese J Resink

http://www.w3.org/2001/XMLSchema#string

Wolfgang Kiowski

http://www.w3.org/2001/XMLSchema#string

P304

1985-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.297.18.1985

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6342426

http://www.w3.org/2001/XMLSchema#string

P698

17488963

http://www.w3.org/2001/XMLSchema#string

P921